Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic significance of clinicopathological factors in early breast cancer: 20 years of follow-up in a single-center analysis.
Cocciolone V, Cannita K, Calandrella ML, Ricevuto E, Baldi PL, Sidoni T, Irelli A, Paradisi S, Pizzorno L, Resta V, Bafile A, Alesse E, Tessitore A, Ficorella C. Cocciolone V, et al. Among authors: bafile a. Oncotarget. 2017 Jun 16;8(42):72031-72043. doi: 10.18632/oncotarget.18526. eCollection 2017 Sep 22. Oncotarget. 2017. PMID: 29069766 Free PMC article.
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations.
Cocciolone V, Cannita K, Tessitore A, Mastroiaco V, Rinaldi L, Paradisi S, Irelli A, Baldi PL, Sidoni T, Ricevuto E, Dal Mas A, Calvisi G, Coletti G, Ciccozzi A, Pizzorno L, Resta V, Bafile A, Alesse E, Ficorella C. Cocciolone V, et al. Among authors: bafile a. Oncotarget. 2018 Jun 8;9(44):27380-27396. doi: 10.18632/oncotarget.25270. eCollection 2018 Jun 8. Oncotarget. 2018. PMID: 29937992 Free PMC article.
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
Irelli A, Parisi A, D'Orazio C, Sidoni T, Rotondaro S, Patruno L, Pavese F, Bafile A, Resta V, Pizzorno L, Ciuffetelli V, Dal Mas A, Calvisi G, Di Sibio A, Marzullo A, Zelli V, Compagnoni C, Tessitore A, Alesse E, Ficorella C, Cortellini A, Cannita K. Irelli A, et al. Among authors: bafile a. Cancers (Basel). 2022 Jun 18;14(12):3003. doi: 10.3390/cancers14123003. Cancers (Basel). 2022. PMID: 35740668 Free PMC article.
[Can analysis of the molecular status of the p53 gene contribute to improving the therapeutic strategy for breast carcinoma?].
Ricevuto E, Marchetti P, Cannita K, De Galitiis F, Di Rocco ZC, Tessitore A, Martella F, Bisegna R, Porzio G, Bafile A, Vicentini R, Resta V, Mattucci S, Ventura T, Martinotti S, de Rubeis GP, Ficorella C. Ricevuto E, et al. Among authors: bafile a. Tumori. 2003 Jul-Aug;89(4 Suppl):197-9. Tumori. 2003. PMID: 12903592 Review. Italian.
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach].
Ricevuto E, Di Rocco ZC, Cianci G, Bisegna R, Casilli F, De Galitiis F, Cannita K, Calista F, Porzio G, Bafile A, Vicentini R, Resta V, De Rubeis G, Martinotti S, Ficorella C, Marchetti P. Ricevuto E, et al. Among authors: bafile a. Suppl Tumori. 2002 May-Jun;1(3):S89-91. Suppl Tumori. 2002. PMID: 12415797 Review. Italian. No abstract available.
The sentinel lymph node in T1N0 breast cancer.
Paolo de Rubeis G, Bafile A, Resta V, Vicentini R. Paolo de Rubeis G, et al. Among authors: bafile a. Tumori. 2000 Jul-Aug;86(4):327-8. doi: 10.1177/030089160008600419. Tumori. 2000. PMID: 11016718
13 results